Vivifrail Exercise Program in Nonagenarians: Effects on Function, Muscle, and Cognition (Vivifrail)
Effects of a Multicomponent Exercise Program Based on the Vivifrail Protocol on Functional Capacity, Muscle Morphology, and Cognition in Nonagenarians: A Randomized Clinical Trial
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
This is a three-arm, parallel-group randomized controlled trial evaluating a home-based multicomponent exercise program based on the Vivifrail protocol in community-dwelling nonagenarians (aged 90 years or older). A total of 54 participants (18 per group) will be randomly allocated to one of three groups: G1, performing the Vivifrail program at least twice a week; G2, performing it at least three times a week; or a control group (GC) maintaining usual activities.
Randomization will be performed using Randomizer software (www.randomizer.org) by an independent researcher not involved in the assessments. Allocation is stratified by sex and by baseline functional level, defined by collapsing the six Vivifrail functional categories into two groups (lower function: Types A, B, and B+; higher function: Types C, C+, and D), to ensure balanced distribution of baseline physical function across the three groups. Each participant is still assigned the individualized Vivifrail training passport corresponding to their specific functional category. Given the autonomous, home-based nature of the intervention, participants and interventionists cannot be blinded; however, outcome assessors remain blinded to group allocation throughout the study.
Assessments occur at three timepoints: baseline (T0), 12 weeks (T1), and 24 weeks (T2). The 24-week intervention is individualized according to each participant's functional profile, determined by the Short Physical Performance Battery (SPPB) and the corresponding Vivifrail training passport.
The primary outcome is physical function measured by the total SPPB score (0-12). Secondary outcomes include mobility (Timed Up and Go and cognitive dual-task cost), handgrip strength, lower-limb power (five-times sit-to-stand with linear encoder), gait speed, balance, muscle morphology of the vastus lateralis (ultrasound), cognition (Mini-Mental State Examination), and change in Vivifrail functional category. Data will be analyzed by intention to treat using generalized estimating equations (GEE), examining the group-by-time interaction.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brasil, 90035-903
- Hospital de Clínicas de Porto Alegre (HCPA) - Geriatrics outpatient clinic
-
Porto Alegre, Rio Grande do Sul, Brasil, 90690-200
- Escola de Educação Física, Fisioterapia e Dança (ESEFID/UFRGS) - and participants' homes
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Aged 90 years or older
- Living in the community (own or family home)
- Able to walk independently or with a walking aid (cane or walker), without third-party assistance
- Minimum cognitive capacity to understand and perform the exercises (MMSE, education-adjusted cutoffs)
- Adequate home conditions to perform the program
- Availability of a family member or caregiver to support the sessions
- Signed informed consent (with legal guardian assistance when needed)
Exclusion Criteria:
- - Total inability to walk or permanent bedridden condition
- Severe cognitive impairment preventing safe understanding and execution of exercises
- Severe orthopedic, neurological, or rheumatological conditions preventing exercise
- Concurrent participation in another structured exercise program
- Anticipated unavailability (relocation, planned hospitalization, or institutionalization) during the intervention
- Refusal to sign informed consent or absence of a legal guardian when required
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Vivifrail - 2 sessions/week (G1)
Home-based Vivifrail multicomponent exercise program performed at least twice a week for 24 weeks, individualized by functional profile (SPPB and Vivifrail passport).
|
Individualized multicomponent home-based training (strength/power, balance, gait, and flexibility) prescribed according to the participant's Vivifrail functional profile.
|
|
Eksperimentell: Vivifrail - 3 sessions/week (G2)
Home-based Vivifrail multicomponent exercise program performed at least three times a week for 24 weeks, individualized by functional profile.
|
Individualized multicomponent home-based training (strength/power, balance, gait, and flexibility) prescribed according to the participant's Vivifrail functional profile.
|
|
Ingen inngripen: Control (GC)
Participants maintain usual activities without a structured exercise program during the 24-week period.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in physical function measured by the Short Physical Performance Battery (SPPB) total score
Tidsramme: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)
|
Total SPPB score ranging from 0 to 12 points (higher scores indicate better lower-extremity physical function), combining balance, gait speed, and chair-stand tests.
|
Baseline (T0), 12 weeks (T1), and 24 weeks (T2)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Mobility - Timed Up and Go (TUG)
Tidsramme: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)
|
ime in seconds to rise, walk 3 meters, turn, return, and sit.
|
Baseline (T0), 12 weeks (T1), and 24 weeks (T2)
|
|
Mobility under dual task - Cognitive TUG and dual-task cost (DTC%) ·
Tidsramme: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)).
|
TUG performed with a concurrent cognitive task; dual-task cost calculated as percentage change relative to single-task TUG.
|
Baseline (T0), 12 weeks (T1), and 24 weeks (T2)).
|
|
Handgrip strength
Tidsramme: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)).
|
Maximal isometric handgrip strength in kilograms, measured with a Jamar dynamometer.
|
Baseline (T0), 12 weeks (T1), and 24 weeks (T2)).
|
|
Lower-limb muscle power - Five-times sit-to-stand
Tidsramme: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)).
|
ime in seconds and estimated lower-limb power measured during the five-times sit-to-stand test using a linear encoder.
|
Baseline (T0), 12 weeks (T1), and 24 weeks (T2)).
|
|
Gait speed
Tidsramme: aseline (T0), 12 weeks (T1), and 24 weeks (T2)).
|
Usual gait speed in meters per second.
|
aseline (T0), 12 weeks (T1), and 24 weeks (T2)).
|
|
Balance
Tidsramme: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)).
|
Static balance assessed by the SPPB balance component (side-by-side, semi-tandem, and tandem stands).
|
Baseline (T0), 12 weeks (T1), and 24 weeks (T2)).
|
|
Change in Vastus Lateralis Muscle Thickness
Tidsramme: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)
|
Vastus lateralis muscle thickness measured by B-mode ultrasound, defined as the distance between the adipose-muscle and muscle-bone interfaces, analyzed in ImageJ by a single trained, blinded assessor.
|
Baseline (T0), 12 weeks (T1), and 24 weeks (T2)
|
|
Change in Vastus Lateralis Echo Intensity (Muscle Quality)
Tidsramme: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)
|
Muscle quality assessed by echo intensity on B-mode ultrasound, expressed in arbitrary units (grayscale, 0-255) via manual region-of-interest analysis in ImageJ, excluding fascia and bone.
Higher echo intensity indicates greater intramuscular fat/fibrous infiltration, i.e., poorer muscle quality.
Single assessor blinded to group allocation.
|
Baseline (T0), 12 weeks (T1), and 24 weeks (T2)
|
|
Cognition - Mini-Mental State Examination (MMSE)
Tidsramme: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)
|
Global cognitive function measured by the MMSE, using education-adjusted cutoffs.
|
Baseline (T0), 12 weeks (T1), and 24 weeks (T2)
|
|
Change in Vivifrail functional category
Tidsramme: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)
|
Transition across Vivifrail functional categories (Types A, B, B+, C, C+, D) over the intervention period.
|
Baseline (T0), 12 weeks (T1), and 24 weeks (T2)
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 79748517.5.0000.5347
- U1111-1343-8083 (Annen identifikator: WHO Universal Trial Number (UTN))
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .